Skip to main content
main-content

Type 2 diabetes

Feature content

08-21-2019 | Diet | Video | Article

Are these popular diets safe for your patients with type 2 diabetes?

WATCH | Egg diets? Alkaline diets? Raspberry ketones? Pam Dyson and Liz Morris discuss how to handle your patients' questions about these dietary approaches and more.

08-14-2019 | Diet | Video | Article

Which diets can I safely recommend to patients with type 2 diabetes?

WATCH | Research Dietitian Pam Dyson and General Practitioner Liz Morris discuss evidence-based dietary recommendations for the management of type 2 diabetes.

08-14-2019 | Diet | Video | Article

Which diets can I safely recommend to patients with type 2 diabetes?

WATCH | Research Dietitian Pam Dyson and General Practitioner Liz Morris discuss the findings from the DiRECT trial, including the real-world implications for recommending a diet that can put type 2 diabetes into remission (2:18).

08-14-2019 | Diet | Video | Article

Which diets can I safely recommend to patients with type 2 diabetes?

WATCH | Research Dietitian Pam Dyson and General Practitioner Liz Morris discuss the efficacy and safety of low-fat healthy eating, low-calorie, Mediterranean and meal replacement diets for the management of type 2 diabetes (4:29).

08-14-2019 | Diet | Video | Article

Which diets can I safely recommend to patients with type 2 diabetes?

WATCH | Research dietitian Pam Dyson and General practitioner Liz Morris discuss the benefits and drawbacks of low-carb diets as well as the positive evidence for structured weight management in people with type 2 diabetes (4:52).

08-06-2019 | SGLT2 inhibitors | Editorial | Article

Cardiorenal syndromes and SGLT2 inhibitor usage

Sanjay Kalra explores the intrinsic link between the cardiovascular and renal systems, focusing on whether the SGLT2 inhibitor class has a role to play in diabetic patients with cardiorenal comorbidity.

07-24-2019 | Artificial pancreas systems | Feature | Article

Adaptive and flexible: Closed-loop technology for all

medwireNews talks to one of the pioneers of closed-loop insulin delivery, Roman Hovorka, about his algorithm, his research so far, and his plans for commercialization.

07-03-2019 | Semaglutide | At a glance | Article

A quick guide to the PIONEER trials

medwireNews rounds up the ongoing, reported, and published trials from the PIONEER oral semaglutide program.

07-02-2019 | Dulaglutide | Podcast | Article

REWIND, DECLARE, and high-risk diabetes patients

How will the findings of the REWIND trial and the DECLARE-TIMI 58 renal outcomes analysis affect treatment decisions for high-risk diabetes patients without overt cardiovascular disease? medwireNews asks Kamlesh Khunti.

06-26-2019 | SGLT2 inhibitors | Feature | Article

Fournier gangrene: A challenge for risk–benefit communication

The recent postmarketing data on Fournier gangrene in people taking sodium-glucose cotransporter 2 inhibitors has increased concerns about this very rare but potentially fatal side effect. medwireNews talks to primary care diabetes specialist Kevin Fernando about how the findings affect risk–benefit considerations.

05-22-2019 | Sulfonylureas | Editorial | Article

The CAROLINA trial: Make or break for sulfonylureas?

Diabetologist Sanjay Kalra puts the CAROLINA trial into historical context and considers the present-day implications for the use of DPP-4 inhibitors and sulfonylureas.

05-17-2019 | Nephropathy | Video | Article

Team-based care for patients with type 2 diabetes and kidney disease

WATCH | Nephrologist Katherine Tuttle and Primary Care Physician Jay Shubrook discuss referrals to nephrology for patients with comorbid diabetes and kidney disease (8:38).

05-03-2019 | Devices and technology | Editorial | Article

Exposure to diabetes technologies: Where now for adult services?

What does the proliferation of diabetes self-management and monitoring technologies in pediatric care mean for the future of adult services? Katharine Barnard looks at the situation in England and Wales.

04-24-2019 | Type 2 diabetes | Feature | Article

Young-onset type 2 diabetes: A different process?

Escalating obesity prevalence and severity has led to type 2 diabetes being diagnosed in ever-younger people, including children. medwireNews rounds up the accumulating evidence suggesting a particularly severe diabetes course in these young people.

04-24-2019 | Primary care | Commentary | Article

Diagnosis age matters when it comes to type 2 diabetes

Editorial board member Jay Shubrook explains how the aggressive course of young-onset type 2 diabetes affects clinical decision-making for primary care providers.

04-17-2019 | Nephropathy | Podcast | Article

Nephrologist expert commentary: The CREDENCE trial

Consultant nephrologist Andrew Frankel tells medwireNews about the rationale and key findings of the CREDENCE trial, and discusses the potential benefits of SGLT2 inhibitors beyond type 2 diabetes (9:45).

04-17-2019 | Nephropathy | Podcast | Article

Primary care expert commentary: The CREDENCE trial

General practitioner Kevin Fernando talks to medwireNews about the importance of the CREDENCE trial from a primary care perspective (4:43).

04-15-2019 | Nephropathy | Podcast | Article

Researcher comment: The CREDENCE trial

Lead investigator Vlado Perkovic talks about the main findings from the CREDENCE trial – demonstrating that canagliflozin is associated with a reduced risk for kidney failure and cardiovascular events in people with type 2 diabetes and chronic kidney disease – and discusses how these results will impact clinical practice (6:51).

04-13-2019 | Nephropathy | Video | Article

Diabetic kidney disease: A call to primary care

WATCH | Nephrologist and Endocrinologist Katherine Tuttle joins Primary Care Physician Jay Shubrook to share best practice tips for kidney disease screening in patients with diabetes (8:16).

04-01-2019 | Nutritional management | Practical approach | Article

A practical guide to delivering nutritional advice to people with diabetes

This article aims to offer a practical guide for health professionals who deliver dietary information to people with diabetes.

Image Credits